Regulation and legislation

Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?

1st April 2021 - Blogs |

The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the list has been put forward, but the speculation is that it will now more than likely be […]

Regulatory report: Poland, March 2021

19th March 2021 - Regulatory reports |

This report offers an overview of the current regulations in place for CBD and cannabis in Poland, including all aspects from cultivation and processing, to finished products, medical and recreational cannabis

Have the rules changed for importation of CBD into the UK?

18th February 2021 - Blogs |

The Home Office has not changed licensing requirements for importers of CBD into the UK. The minister for policing, Christopher “Kit” Malthouse, has requested an updated recommendation from the Advisory Council on the Misuse of Drugs (ACMD) on acceptable THC levels in CBD consumer products. The ACMD has not yet responded and the previous limit of […]

Will the EFSA look to modify its approach in light of action on novel food in the UK?

12th February 2021 - Blogs |

The European Food Safety Authority (EFSA) has stated that it is in contact with other similar agencies such as the Food Standards Agency (FSA) in the UK, but only specified that it would not treat applications that had been approved in other jurisdictions any differently during its own assessment process. But beyond that, it has not stated […]

Regulatory report: Canada, February 2021

8th February 2021 - Regulatory reports |

Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules

What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?

28th January 2021 - Blogs |

The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make […]

Does the Canopy CO2 extraction lawsuit pose a threat to others in the industry?

15th January 2021 - Blogs |

Canopy Growth’s quick action – filing a suit against GW Pharmaceuticals the day the patent was issued – coupled with the short time-frame for validity has left many worried that the company could go on an enforcement hunt and target any company using a CO2 method that it believes infringes on its intellectual property (IP). […]

Regulatory report: Philippines, January 2021

13th January 2021 - Regulatory reports |

A debate on regulating cannabis for medicinal use is on the table in the Philippines, and several bills are currently being discussed. This report provides an overview of the current regulatory regime for CBD and cannabis in the country